Eisai invests
January 26, 2006Manufacturing and Production
Japanese pharma company Eisai is to open a major new single site facility in the UK, marking the country out …
Amgen to expand R&D investment in UK
January 26, 2006Research and Development
Amgen, the world's largest biotechnology company is to open a new drug development centre in Uxbridge, London, as part of …
Helping marketers to break ranks
January 26, 2006Business Services
In the pharma industry personnel development seems to be viewed from a short-term perspective. Where personnel development is undertaken, process …
Limited access to Alzheimer’s drugs leaves patients groups dissatisfied
January 25, 2006Sales and Marketing
Patient groups have expressed disappointment at NICE plans to allow only some patients with Alzheimer's disease to have drug treatment, …
Roche and biotech swap roles in novel collaboration
January 24, 2006Research and Development
Roche and Amira Pharmaceuticals have entered into a new and unorthodox drug discovery and development partnership which will see them …
Mergers will create gulf between GPs and PCTs
January 20, 2006Health service leaders have warned that planned mergers of Primary Care Trusts in England will create larger bodies more remote …
Wyeth submits follow-up to antidepressant blockbuster
January 20, 2006Sales and Marketing
Wyeth has submitted its new antidepressant desvenlafaxine to the FDA, a drug it hopes will be a successor to its …
Next generation hypertension drug ready for 2006 filing
January 20, 2006Sales and Marketing
Next generation hypertension drug aliskiren is on track for filing in late 2006 and is showing promising results in the …
Campaign to raise awareness of pharma code of conduct
January 20, 2006Medical Communications
The UK pharmaceutical industry's newly re-drafted code of conduct is to benefit from a PR campaign to promote awareness of …
Next generation monoclonal antibodies to enter clinical trials in 2007
January 20, 2006Research and Development Ablynx, Novartis
Novartis has signed a deal with Belgium biotech Ablynx to develop the next generation of monoclonal antibodies with clinical development …
FDA looks to streamline early research
January 19, 2006Research and Development
The FDA has unveiled plans to allow more small-scale exploratory studies of drugs in humans before formal phase I studies …
Novartis to appeal Zelnorm rejection
January 18, 2006Sales and Marketing
Novartis says it will appeal against an EMEA decision not to recommend its irritable bowel syndrome drug Zelnorm. Zelnorm (tegaserod) …
Prescribers ready to defy NICE in Alzheimer’s drug row
January 18, 2006Sales and Marketing
Patient groups and manufacturers are hoping NICE will reverse its decision to deny access to Alzheimer's drugs on the NHS, …
First-in-class indication expected for Remicade
January 18, 2006Sales and Marketing
Schering-Plough expects its arthritis treatment Remicade to receive European approval to treat ulcerative colitis in early 2006.If approved Remicade (infliximab) …
StayinFront wins Roche regional contract
January 18, 2006Business Services
Roche will equip its Central and Eastern European salesforces with StayinFront customer relationship management software after expanding its current contract …
Patient-led NHS revolution to continue, says under fire Hewitt
January 18, 2006Patricia Hewitt has pledged to press ahead with the next phase of Labour's NHS reforms, despite renewed opposition from within …
Merck in race to bring first cervical cancer vaccine to market
January 18, 2006Sales and Marketing
Merck and GlaxoSmithKline are head-to-head in a race to establish a market for their rival cervical cancer vaccines, both set …
Drinking straw a novel antibiotic delivery for children
January 17, 2006Sales and Marketing
A new drinking straw that administers antibiotics to children as they drink has been launched by German pharma company Grunenthal.Clarosip …
Virgo Health wins Cymbalta account
January 17, 2006Medical Communications
Virgo Health has been appointed to promote depression brand Cymbalta to healthcare professionals in the UK following a two-way competitive …
Right time, right place, right patient
January 17, 2006Research and Development
With patient recruitment such a key cog in the overall clinical trial machine, pharma and biotech businesses are increasing their …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
